Next Pharmaceutical City of Hyderabad Will Be Exporter Friendly: Official

The upcoming Hyderabad Pharma City will give pharmaceutical exports a big boost, according to Jayesh Ranjan, Principal Secretary, Industries and Commerce, Telangana government.

Speaking at the inauguration of a two-day pharmaceutical exhibition and conference jointly organized by the Pharmaceutical Export Promotion Council (Pharmexcil) and the state government in celebration of the 75th anniversary of the India’s independence here on Tuesday, the official said that end-to-end facilities will be provided in the pharmaceutical city.

The state is developing Hyderabad Pharma City as a world-class sustainable industrial hub and is in the process of acquiring land in Ranga Reddy district. “The pharmaceutical city will have a complete infrastructure for exporters. In addition, we are also developing a fleet of medical devices, ” Jayesh Ranjan said, adding that exporters play a crucial role in achieving higher growth in gross domestic product.

Also Read: Hyderabad Pharma City To Have 306 Crore Housing Colony

In his opening speech, Krishna Ella, Chairman and CEO of Bharat Biotech International Limited, said that innovation is vital in the pharmaceutical and biotechnology industry and that human resources and skills are important for growth driven by innovation. “China has succeeded because of her skills, even though her language skills are not very good,” Ella added.

In his welcome speech, R Uday Bhaskar, Managing Director of Pharmexcil, said: “Hyderabad used to be called the Bulk Medicine Capital of India, but now it is called the Vaccine Capital.

India has so far provided 66 crore of vaccine doses to more than 95 countries, said Uday Bhaskar, adding that of the world’s 20 largest pharmaceutical companies, eight are from India, including two from Hyderabad, said. he added.

Source link

About Margie Peters

Check Also

NOXXON Pharma Announces Upcoming Oral Presentation at 2021 Society for Neuro-Oncology Annual Meeting

BERLIN–(COMMERCIAL THREAD) – Regulatory news: NOXXON Pharma SA (Euronext Growth Paris: ALNOX), a biotechnology company …

Leave a Reply

Your email address will not be published. Required fields are marked *